Diabetes Clinical Trials

Showing 5181-5200 of 7,874 trials

DREAM Project Community Health Worker Intervention

NCT02041598

The DREAM (Diabetes Research, Education, and Action for Minorities) Project is a Community Health Worker (CHW) intervention to improve diabetic management and control among Bangladeshis with diabetes in New York City (NYC).

Diabetes Mellitus, Type 2

NYU Langone Health441 participantsStarted Jul 2009

New York, New York, United States

COMPLETEDPhase 2

A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263

NCT01128621

A study in type 2 diabetic subjects on stable metformin therapy to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of co-administering single and multiple oral doses of GSK1292263

Diabetes Mellitus, Type 2

GlaxoSmithKline66 participantsStarted Nov 2009

Chula Vista, California, United States • Miami, Florida, United States

COMPLETEDPhase 1

An Assessment of Pharmacokinetic Gemigliptin and Metformin Interactions in Healthy Mexican Volunteers

NCT03310749

This is an open, randomized (randomization ratio: 1:1), multiple dose, three way, three period cross over study to assess the potential for drug drug interactions between gemigliptin (a DPP-IV inhibitor mainly metabolized by CYP3A4) and metformin in a sample of healthy Mexican volunteers, aimed to determine whether the observed lack of drug-drug interactions between gemigliptin and metformin in the Korean population is reproducible in an ethnically different population characterized by a significant difference in the frequency of CYP3A4 polymorphisms associated with decreased enzymatic activity, such as CYP3A4\*1b, in comparison with Asian populations.

Diabetes Mellitus, Type 2

Stendhal Americas, S.A.34 participantsStarted Jan 2016

Nezahualcóyotl, State of Mexico, Mexico

DREAM Project Community Health Worker Intervention

A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263

An Assessment of Pharmacokinetic Gemigliptin and Metformin Interactions in Healthy Mexican Volunteers

Related Searches

A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin

Effect of Breakfast or Omission of Breakfast in T2D

The Work of Being a Patient With Diabetes: Data Collection Via a Smartphone Application

Effects of Whey Protein in Type 2 Diabetics

The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers

A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus

Magnetic Resonance Angiography to Diagnose Atherosclerotic Disease

Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)

Effects of Physical Exercise in Type 2 Diabetics

Improving Outcomes for Individuals With Serious Mental Illness and Diabetes

Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics

Families on Track: A Digital Health Behavioral Intervention for Parents Seeking Treatment for Their Child With Obesity

Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes

Preschool CGM Use and Glucose Variability in Type 1 Diabetes

Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control

Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics

BIOFLOW-III Israel Satellite Registry